NCT00632086已完成1 期
A Phase 1, Open-Label, Randomized, 3-Way Crossover Study to Evaluate the Relative Bioavailability of a Single Oral Dose of Aspirin Administered as PA32540 (Aspirin/Omeprazole) or as the Aspirin Component of PA32540 or as Ecotrin® 325 mg in Healthy Volunteers
POZEN0 个研究点目标入组 36 人开始时间: 2008年2月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 36
研究概览
简要总结
Study to determine a single dose bioavailablity of PA32540 is similar to EC aspirin 325 mg with respect to salicylic acid.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 55 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Standard for PK
- •Ages 18-55 years old
- •Males and females
排除标准
- •Standard for PK
研究组 & 干预措施
1
Experimental
Single oral dose of 325 mg aspirin administered as PA32540
干预措施: PA32540 (Drug)
2
Experimental
aspirin core
干预措施: aspirin component of PA32540 (Drug)
3
Active Comparator
active
干预措施: Ecotrin (Drug)
研究者
相似试验
已完成
1 期
A Relative Bioavailability Study of Two Formulations of BCX7353Hereditary AngioedemaNCT03202784BioCryst Pharmaceuticals24
已完成
1 期
Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy SubjectsHypertensionNCT03657550Conjupro Biotherapeutics, Inc.36
已完成
1 期
Relative Bioavailability and Food Effect of SYHA1813 Oral Solution in Healthy ParticipantsHealthy ParticipantsNCT06157918Shanghai Runshi Pharmaceutical Technology Co., Ltd19
已完成
1 期
Study to Assess the Bioavailability, Pharmacokinetics, Safety, and Tolerability of AVP-923 in Healthy Adult ParticipantsHealthy Adult Male and Female VolunteersNCT03381664Avanir Pharmaceuticals17
已完成
1 期
A Study of JNJ-70033093 in Healthy ParticipantsHealthyNCT04448964Janssen Research & Development, LLC24